Impact of fenofibrate on NAFLD/NASH: A genetic perspective
Authors:
- 16 May 2022
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 27 (8) , 2363-2372
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Dietary Fructus Schisandrae extracts and fenofibrate regulate the serum/hepatic lipid-profile in normal and hypercholesterolemic mice, with attention to hepatotoxicityLipids in Health and Disease, 2012
- Metabolic Adaptation Follows Contractile Dysfunction in the Heart of Obese Zucker Rats Fed a High-Fat “Western” DietObesity, 2010
- Effect of Fenofibrate and Niacin on Intrahepatic Triglyceride Content, Very Low-Density Lipoprotein Kinetics, and Insulin Action in Obese Subjects with Nonalcoholic Fatty Liver DiseaseThe Journal of Clinical Endocrinology & Metabolism, 2010
- Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic DiseaseCell, 2010
- Fenofibrate differentially regulates plasminogen activator inhibitor-1 gene expression via adenosine monophosphate–activated protein kinase–dependent induction of orphan nuclear receptor small heterodimer partner #Hepatology, 2009
- A class of imidazolium salts is anti-oxidative and anti-fibrotic in hepatic stellate cellsFree Radical Research, 2009
- Nrf2- and PPARα-Mediated Regulation of Hepatic Mrp Transporters after Exposure to Perfluorooctanoic Acid and Perfluorodecanoic AcidToxicological Sciences, 2008
- The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in miceLife Sciences, 2008
- Alterations in Adipose Tissue and Hepatic Lipid Kinetics in Obese Men and Women With Nonalcoholic Fatty Liver DiseaseGastroenterology, 2008
- Molecular Cloning and Functional Expression of a Human Peroxisomal Acyl-Coenzyme A OxidaseBiochemical and Biophysical Research Communications, 1994